LivaNova LIVN recently announced new data from the PolySync substudy showing that its PolySync programming algorithm ...
LivaNova’s proprietary PolySync algorithm allows for proximal hypoglossal nerve stimulation (p-HGNS) stimulation fields to be ...
LivaNova (Nasdaq:LIVN) today announced new data demonstrating the success of its PolySync programming algorithm for sleep ...
LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced new data showing that use of its PolySync™ programming algorithm increased the ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced new data showing that use of its PolySync™ programming algorithm increased the cumulative apnea-hypopnea index ...
LivaNova's PolySync algorithm raised the AHI response rate to 84.5% in moderate to severe OSA patients. LivaNova shares slipped 0.3% after the news but remain up 29.1% YTD against an industry fall.